GvHD Prophylaxis

Practice-changing abstracts for GvHD from ASH 2019

L: English

The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this interview, Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR, discusses practice-changing abstracts in the field of graft-versus-host disease that were presented during ASH 2019.

Mohamad Mohty talks about the benefits of stem cell transplantations and explains that it comes at a cost of complications such as graft-versus-host disease. He also discusses different prophylaxis regimens that are offered to patients and how that affects patient responses. He talks about the success of post-transplant cyclophosphamide in the haploidentical setting and questions its efficacy if it were to be translated into the identical sibling/unrelated setting. He also discusses the anticipated results of the HOVON trial. He concludes by discussing novel interventions such as the use of fecal microbiota transplant

Was this article informative? Thank you for your feedback!